RetractedTrialCNS neuroscience & therapeutics2021

Double-blind, randomized, placebo-controlled pilot study of the phosphodiesterase-3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorder.

Mahmoud S Abdallah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.